{"count":11,"next":null,"previous":null,"results":[{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"1","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Red","UKGTN"],"phenotypes":["Glycogen Storage Disease"],"mode_of_inheritance":"Unknown","tags":[],"panel":{"id":248,"hash_id":"5554c896bb5a161bf644a3cf","name":"Ketotic hypoglycaemia","disease_group":"Metabolic disorders","disease_sub_group":"Specific metabolic abnormalities","status":"public","version":"1.2","version_created":"2017-11-05T02:37:20.297525Z","relevant_disorders":[],"stats":{"number_of_genes":44,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":["27604308","10932264","14722920"],"evidence":["Emory Genetics Laboratory","UKGTN","Expert Review","Radboud University Medical Center, Nijmegen"],"phenotypes":["Epilepsy, progressive myoclonic 2A (Lafora)\t254780"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":265,"hash_id":"55b6173522c1fc05fc7a1855","name":"Early onset dementia (encompassing fronto-temporal dementia and prion disease)","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Neurodegenerative disorders","status":"public","version":"1.48","version_created":"2019-06-20T15:15:01.659131Z","relevant_disorders":[],"stats":{"number_of_genes":31,"number_of_strs":9,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["27604308","10932264","14722920"],"evidence":["Expert Review Green"],"phenotypes":["Epilepsy, progressive myoclonic 2A (Lafora)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":477,"hash_id":null,"name":"Ataxia and cerebellar anomalies - narrow panel","disease_group":"","disease_sub_group":"","status":"public","version":"1.7","version_created":"2019-09-20T16:56:48.672242Z","relevant_disorders":[],"stats":{"number_of_genes":199,"number_of_strs":13,"number_of_regions":3},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["NHS GMS","Wessex and West Midlands GLH","Expert Review Green"],"phenotypes":["Epilepsy, progressive myoclonic 2A (Lafora) 254780"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":528,"hash_id":null,"name":"Glycogen storage disease","disease_group":"","disease_sub_group":"","status":"public","version":"1.0","version_created":"2019-08-13T11:59:56.108304Z","relevant_disorders":["R274"],"stats":{"number_of_genes":28,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"GMS signed-off","slug":"gms-signed-off","description":"This panel has undergone review by a NHSE GMS disease specialist group and processes to be signed-off for use within the GMS."}]}},{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":["27604308","10932264","14722920"],"evidence":["Expert Review","Emory Genetics Laboratory","UKGTN","Radboud University Medical Center, Nijmegen"],"phenotypes":["Epilepsy, progressive myoclonic 2A (Lafora)\t254780"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":20,"hash_id":"559a7d1022c1fc58ad67fc97","name":"Hereditary ataxia","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Motor Disorders of the CNS","status":"public","version":"1.202","version_created":"2019-06-20T15:15:07.878228Z","relevant_disorders":[],"stats":{"number_of_genes":160,"number_of_strs":14,"number_of_regions":3},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["27604308","10932264","14722920"],"evidence":["Wessex and West Midlands GLH","Yorkshire and North East GLH","NHS GMS","London North GLH","Expert Review Green"],"phenotypes":["Epilepsy, progressive myoclonic 2A (Lafora) 254780"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":474,"hash_id":null,"name":"Neurodegenerative disorders - adult onset","disease_group":"","disease_sub_group":"","status":"public","version":"1.106","version_created":"2019-09-20T16:19:10.101841Z","relevant_disorders":["R58"],"stats":{"number_of_genes":395,"number_of_strs":18,"number_of_regions":4},"types":[{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":["27604308"],"evidence":["Expert Review Green","Radboud University Medical Center, Nijmegen","Emory Genetics Laboratory","UKGTN","Literature"],"phenotypes":["Epilepsy, progressive myoclonic 2A (Lafora)\t254780"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":302,"hash_id":"5763f1518f620350a22bccdb","name":"Undiagnosed metabolic disorders","disease_group":"Metabolic disorders","disease_sub_group":"Specific metabolic abnormalities","status":"public","version":"1.373","version_created":"2019-10-08T14:47:17.153678Z","relevant_disorders":["Undiagnosed Metabolic Panel"],"stats":{"number_of_genes":744,"number_of_strs":1,"number_of_regions":1},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["27604308"],"evidence":["London North GLH","NHS GMS","Expert Review Green"],"phenotypes":["Epilepsy, progressive myoclonic 2A (Lafora)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":467,"hash_id":null,"name":"Inborn errors of metabolism","disease_group":"","disease_sub_group":"","status":"public","version":"1.348","version_created":"2019-10-09T08:19:52.386941Z","relevant_disorders":["Likely inborn error of metabolism - targeted testing not possible"],"stats":{"number_of_genes":877,"number_of_strs":2,"number_of_regions":1},"types":[{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":null,"publications":["14722920","10932264","16134145","11175283"],"evidence":["Wessex and West Midlands GLH","NHS GMS","NIHRBR-RD Consortium SPEED_v3.0_20170404","Victorian Clinical Genetics Services","Expert Review Green","Expert"],"phenotypes":["Epilepsy, progressive myoclonic 2A (Lafora) 254780"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":402,"hash_id":null,"name":"Genetic epilepsy syndromes","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Inherited Epilepsy Syndromes","status":"public","version":"1.363","version_created":"2019-10-08T10:06:11.607307Z","relevant_disorders":["Epilepsy Plus","Epilepsy plus other features","Genetic Epilepsy Syndromes","Epileptic encephalopathy","Familial Focal Epilepsies","Familial Genetic Generalised Epilepsies","Genetic Epilepsies with Febrile Seizures Plus (GEFS+)","Genetic Epilepsies with Febrile Seizures Plus"],"stats":{"number_of_genes":614,"number_of_strs":2,"number_of_regions":13},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"1","penetrance":"Complete","mode_of_pathogenicity":"","publications":["21376300"],"evidence":["Expert Review Red","Expert Review Amber","BRIDGE study SPEED NEURO Tier1 Gene"],"phenotypes":["Epilepsy, progressive myoclonic 2A (Lafora)  254780"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":285,"hash_id":"558aa423bb5a16630e15b63c","name":"Intellectual disability","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Neurodevelopmental disorders","status":"public","version":"2.1065","version_created":"2019-10-07T13:42:16.019766Z","relevant_disorders":["Coarse facial features including Coffin-Siris-like disorders","ID","Moderate","severe or profound intellectual disability","Schizophrenia plus additional features","Intellectual disability - microarray","fragile X and sequencing"],"stats":{"number_of_genes":2253,"number_of_strs":11,"number_of_regions":57},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["LDE","LD"],"biotype":"protein_coding","hgnc_id":"HGNC:3413","gene_name":"EPM2A, laforin glucan phosphatase","omim_gene":["607566"],"alias_name":null,"gene_symbol":"EPM2A","hgnc_symbol":"EPM2A","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"6:145822719-146057160","ensembl_id":"ENSG00000112425"}},"GRch38":{"90":{"location":"6:145382535-145736023","ensembl_id":"ENSG00000112425"}}},"hgnc_date_symbol_changed":"1998-10-01"},"entity_type":"gene","entity_name":"EPM2A","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["27604308","14722920","10932264"],"evidence":["London North GLH","NHS GMS","Wessex and West Midlands GLH","Expert Review Green","Hereditary ataxia v1.148"],"phenotypes":["Progressive myoclonic epilepsy 2A, Lafora, 254780","Epilepsy, progressive myoclonic 2A (Lafora) 254780"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":466,"hash_id":null,"name":"Hereditary ataxia - adult onset","disease_group":"","disease_sub_group":"","status":"public","version":"1.211","version_created":"2019-09-20T14:18:40.957460Z","relevant_disorders":["Hereditary ataxia with onset in adulthood","R54"],"stats":{"number_of_genes":236,"number_of_strs":13,"number_of_regions":4},"types":[{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}}]}